Cystadane is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Rare Disease Therapeutics, Inc.. The primary component is Betaine.
| Product ID | 66621-4000_d797121e-e13a-41b8-b7d7-e104ba26077c |
| NDC | 66621-4000 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cystadane |
| Generic Name | Betaine |
| Dosage Form | Powder, For Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 1996-10-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020576 |
| Labeler Name | Rare Disease Therapeutics, Inc. |
| Substance Name | BETAINE |
| Active Ingredient Strength | 6 g/1 |
| Pharm Classes | Methylating Activity [MoA],Methylating Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1996-10-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020576 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 1996-10-25 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| BETAINE | 6 g/1 |
| SPL SET ID: | 84f7c21f-d0af-4ae6-9cd5-d5af96ade329 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52276-400 | Cystadane | betaine |
| 52276-401 | Cystadane | betaine |
| 64811-400 | Cystadane | BETAINE |
| 66621-4000 | Cystadane | betaine |
| 70993-0005 | ATONO2 Oxygen Baby | Betaine |
| 0713-0352 | Betaine | Betaine |
| 55792-002 | Betaine Anhydrous For Oral Solution | betaine |
| 83071-020 | Dr.Jucre Rebirth Activating Toner | Betaine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CYSTADANE 74609648 2055894 Live/Registered |
RECORDATI ORPHAN DRUGS 1994-12-12 |